tocopherols has been researched along with Bisphosphonate Osteonecrosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| da Motta Silveira, FM; de Andrade Veras, SR; de Lima E Silva, DF; de Mello, MJG; Magalhães, JMI; Regueira, LS | 1 |
| Abdelsamie, S; Campbell, CB; Fielding, AF; Heifetz-Li, JJ; Mulligan, JP; Roth, S | 1 |
| Cavalcante, RC; Tomasetti, G | 1 |
| Bertotti, M; de Carvalho E, F; Migliorati, CA; Rocha, AC | 1 |
| Magremanne, M; Reychler, H | 1 |
| Estilo, CL; Huryn, JM; Owosho, AA; Yom, SK | 1 |
2 review(s) available for tocopherols and Bisphosphonate Osteonecrosis
| Article | Year |
|---|---|
Systematic review of the use of pentoxifylline and tocopherol for the treatment of medication-related osteonecrosis of the jaw.
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Humans; Osteoradionecrosis; Pentoxifylline; Phosphodiesterase Inhibitors; Tocopherols | 2019 |
Pentoxifylline and tocopherol protocol to treat medication-related osteonecrosis of the jaw: A systematic literature review.
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Humans; Mandible; Osteonecrosis; Pentoxifylline; Tocopherols | 2020 |
4 other study(ies) available for tocopherols and Bisphosphonate Osteonecrosis
| Article | Year |
|---|---|
Pentoxifylline and tocopherol as prophylaxis for osteonecrosis of the jaw due to bone-modifying agents in patients with cancer submitted to tooth extraction: a case series.
Topics: Adolescent; Adult; Aged; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Humans; Male; Middle Aged; Pentoxifylline; Tocopherols; Tooth Extraction | 2023 |
Cilostazol and Tocopherol in the Management of Medication-Related Osteonecrosis of the Jaw: New Insights From a Case Report.
Topics: Aged; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cilostazol; Female; Humans; Osteonecrosis; Osteoradionecrosis; Pharmaceutical Preparations; Tocopherols | 2021 |
Pentoxifylline and tocopherol in the treatment of yearly zoledronic acid-related osteonecrosis of the jaw in a corticosteroid-induced osteoporosis.
Topics: Adrenal Cortex Hormones; Alendronate; Antioxidants; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Injections, Intravenous; Male; Middle Aged; Osteoporosis; Pentoxifylline; Tocopherols; Tooth Extraction; Zoledronic Acid | 2014 |
Pentoxifylline and tocopherol in the management of cancer patients with medication-related osteonecrosis of the jaw: an observational retrospective study of initial case series.
Topics: Aged; Antioxidants; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Multiple Myeloma; Pentoxifylline; Retrospective Studies; Tocopherols; Treatment Outcome | 2016 |